Follow the 보령 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 보령 has recorded 7 insider filings. Market capitalisation: €685.1bn. The latest transaction was disclosed on 22 June 2026 (Other). Among the most active insiders: 보령홀딩스. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Boryung is a company in the health and pharmaceutical sector, listed on the XKRX. It specializes in the development and marketing of pharmaceutical products.